Structure of human cytidine deaminase bound to a potent inhibitor

Sang J. Chung; J. Christopher Fromme; Gregory L. Verdine

doi:10.1021/jm0496279

Structure of human cytidine deaminase bound to a potent inhibitor

Sang J. Chung
, J. Christopher Fromme
, Gregory L. Verdine

Harvard University
Korea Research Institute of Bioscience and Biotechnology

Research output: Contribution to journal › Article › peer-review

69 Scopus citations

Abstract

Human cytidine deaminase (CDA) is an enzyme prominent for its role in catalyzing metabolic processing of nucleoside-type anticancer and antiviral agents. It is thus a promising target for the development of small molecule therapeutic adjuvants. We report the first crystal structure of human CDA as a complex with a tight-binding inhibitor, diazepinone riboside 1. The structure reveals that inhibitor 1 is able to establish a canonical π/π-interaction with a key active site residue, Phe 137.

Original language	English
Pages (from-to)	658-660
Number of pages	3
Journal	Journal of Medicinal Chemistry
Volume	48
Issue number	3
DOIs	https://doi.org/10.1021/jm0496279
State	Published - 10 Feb 2005
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1021/jm0496279

Cite this

@article{d628c5907ae1481591ef4503d21b2af0,

title = "Structure of human cytidine deaminase bound to a potent inhibitor",

abstract = "Human cytidine deaminase (CDA) is an enzyme prominent for its role in catalyzing metabolic processing of nucleoside-type anticancer and antiviral agents. It is thus a promising target for the development of small molecule therapeutic adjuvants. We report the first crystal structure of human CDA as a complex with a tight-binding inhibitor, diazepinone riboside 1. The structure reveals that inhibitor 1 is able to establish a canonical π/π-interaction with a key active site residue, Phe 137.",

author = "Chung, \{Sang J.\} and Fromme, \{J. Christopher\} and Verdine, \{Gregory L.\}",

year = "2005",

month = feb,

day = "10",

doi = "10.1021/jm0496279",

language = "English",

volume = "48",

pages = "658--660",

journal = "Journal of Medicinal Chemistry",

issn = "0022-2623",

publisher = "American Chemical Society",

number = "3",

}

TY - JOUR

T1 - Structure of human cytidine deaminase bound to a potent inhibitor

AU - Chung, Sang J.

AU - Fromme, J. Christopher

AU - Verdine, Gregory L.

PY - 2005/2/10

Y1 - 2005/2/10

N2 - Human cytidine deaminase (CDA) is an enzyme prominent for its role in catalyzing metabolic processing of nucleoside-type anticancer and antiviral agents. It is thus a promising target for the development of small molecule therapeutic adjuvants. We report the first crystal structure of human CDA as a complex with a tight-binding inhibitor, diazepinone riboside 1. The structure reveals that inhibitor 1 is able to establish a canonical π/π-interaction with a key active site residue, Phe 137.

AB - Human cytidine deaminase (CDA) is an enzyme prominent for its role in catalyzing metabolic processing of nucleoside-type anticancer and antiviral agents. It is thus a promising target for the development of small molecule therapeutic adjuvants. We report the first crystal structure of human CDA as a complex with a tight-binding inhibitor, diazepinone riboside 1. The structure reveals that inhibitor 1 is able to establish a canonical π/π-interaction with a key active site residue, Phe 137.

UR - https://www.scopus.com/pages/publications/13444265938

U2 - 10.1021/jm0496279

DO - 10.1021/jm0496279

M3 - Article

C2 - 15689149

AN - SCOPUS:13444265938

SN - 0022-2623

VL - 48

SP - 658

EP - 660

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

IS - 3

ER -

Structure of human cytidine deaminase bound to a potent inhibitor

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this